Skip to content
Screener

Fulgent Genetics, Inc. FLGT Laboratory Services — Interest Expense Nonoperating

Other segment segments

Therapeutic Development
$0

Similar metrics at other companies

Consolidated Water Company logo
CWCOServices — Interest Expense Nonoperating
$237-80.0%
National Healthcare logo
NHCHomecare Services — Interest Expense Nonoperating
$0
National Healthcare logo
NHCInpatient Services — Interest Expense Nonoperating
$13K-99.3%
Reliance logo
RSMetals Service Centers — Interest Expense Nonoperating
$18.2M+27.3%
Information Services Group logo
IIIFact Based Sourcing Advisory Services — Interest Expense Nonoperating
$897K-14.2%
Brown & Brown logo
BRORetail — Interest Expense Nonoperating
$5M-66.7%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating loss(34,622)(19,795)
Other income (expenses)
Interest income8,6518,018
Interest expense(17)(14)
Other income, net1068
Total other income, net8,6448,072
Loss before income taxes(25,978)(11,723)
(Benefit from) provision for income taxes(704)176

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating?
Fulgent Genetics, Inc. (FLGT) reported laboratory services — interest expense nonoperating of $17K in Q1 2026.
How has Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating changed year-over-year?
Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating increased by 21.4% year-over-year, from $14K to $17K.
What is the long-term trend for Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating?
Over 2 years (2022 to 2025), Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating has grown at a -72.8% compound annual growth rate (CAGR), from $1.01M to $75K.
What does laboratory services — interest expense nonoperating mean?
This metric captures the non-operating interest costs incurred by the laboratory services segment, typically related to debt financing or lease obligations. Monitoring this expense is essential for understanding the segment's cost of capital and the impact of leverage on its overall financial performance.

Ask your AI about Fulgent Genetics, Inc.'s laboratory services — interest expense nonoperating.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude